Tibor Keler Net Worth & Insider Trades

Tibor Keler - EXECUTIVE VP & CSO, Celldex Therapeutics, Inc

As of June 20, 2023

What is Tibor Keler's Net Worth?

The current estimated net worth of Celldex Therapeutics, Inc's EXECUTIVE VP & CSO, Tibor Keler, is estimated to be about $817.57K . Tibor Keler owns about 7,357 units of Celldex Therapeutics, Inc common stock. In the last 14 years at Celldex Therapeutics, Inc, Tibor Keler has sold an estimated value of $622.61K worth.

What is Tibor Keler's Past Insider Trading?

Tibor Keler's largest purchase order was 16,860 units , worth over $46.87K on December 9, 2022. Tibor Keler's largest sale order was 16,860 units , worth over $622.61K on December 9, 2022. In total, Tibor Keler has made about 21 transactions over 14 years of their time at Celldex Therapeutics, Inc. Tibor Keler usually trades in June, with the busiest year in 2020, 2016, 2011, 2010, 2018 and 2022.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Tibor Keler's' Mailing Address?

  • Mailing address is 30 Park Road Ottsville PA 18942 PA

Celldex Therapeutics, Inc Executive Compensation

Name
Year
Other Earnings Plans or Compensations
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Change in Pension Value
Other Compensation
Total
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/744218/000110465921055589/tm212386-1_def14a.htm

What are Celldex Therapeutics, Inc's Past Insider Trades?

Celldex Therapeutics, Inc's most recent insider trade came on December 9, 2022 by Tibor Keler who sold 16,860 units worth $622.61K . In the last 14 years, insiders at Celldex Therapeutics, Inc have sold an estimated value of $32.29M and bought an estimated value of $5.89M worth of shares. Insider trading is most common in June, with the busiest year in 2018. The most active traders at the company are Gerald McMahon, Director,  Anthony S Marucci, PRESIDENT & CEO,  and Tibor Keler, EXECUTIVE VP & CSO .

Celldex Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...